Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Sorafenib Active Against Hormone-Refractory Prostate Cancer
Link ID 1920
Title Sorafenib Active Against Hormone-Refractory Prostate Cancer
Url http://www.medscape.com/viewarticle/567912?src=rss
Description Sorafenib, an agent with both antiangiogenic and antiproliferative activity, may represent a useful treatment for progressive hormone-refractory prostate cancer, new research suggests. Reuters Health Information
Category Articles > Pharmacists
Keywords
Date Dec 27, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. EU to Set New Biosimilar Drug Rules by Mid-YearEU to Set New Biosimilar Drug Rules by Mid-Year
  European regulators will detail the requirements for copies of multiple types of biotech drugs by mid-2012. Reuters Health Information
Category:   Articles > Pharmacists


2. Impact of Renin-Angiotensin-Aldosterone Blockade by Angiotensin-Converting Enzyme Inhibitors or AT-1
  This study suggests a link between renin-angiotensin-aldosterone blocker therapy and contrast medium-induced nephropathy. Nephrology Dialysis Transplantation
Category:   Articles > Pharmacists


3. Apart From the Hole: New Theory Proposes "AF-Like" Theory for Stroke in PFO Patients, With No Right-
  A new study suggests that people with PFOs and moderate to large atrial septal aneurysms may develop left atrial dysfunction something akin to atrial fibrillation, which can cause arterial embolization originating in the left atrium. Heartwire
Category:   Articles > Pharmacists


4. Sublingual Asenapine an Option for Acute Bipolar Mania: Study
  A fast-dissolving sublingual formulation of the second-generation antipsychotic asenapine is a viable option for patients with bipolar I disorder experiencing an acute manic episode, according to a study reported in the November issue of Bipolar Disorders. Reuters Health Information
Category:   Articles > Pharmacists


5. Abatacept Cost-Effective for Treatment Rheumatoid Arthritis
  The selective costimulation modulator abatacept is cost-effective in the treatment of patients with moderate-to-severe rheumatoid arthritis (RA), investigators report in the Journal of Rheumatology. Reuters Health Information
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS